Who
Chen Lichtenstein
Director
Company insider
Files Form 4 as: Director, Teva Pharmaceutical Industries.
In numbers
- Trades disclosed
- 10
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 2 Dec 2024
- Last trade
- 5 Jun 2026
- Last filed
- 8 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 5 Jun 2026filed 8 Jun 2026 | TEVA Teva Pharmaceutical IndustriesPharmaceuticals | SEC FORM 4 Code M | —14,492 | filing |
| 5 Jun 2026filed 8 Jun 2026 | TEVA Teva Pharmaceutical Industriesoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —14,492 at $0.00 | filing |
| 5 Jun 2026filed 8 Jun 2026 | TEVA Teva Pharmaceutical Industriesoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —14,492 at $0.00 | filing |
| 5 Jun 2026filed 8 Jun 2026 | TEVA Teva Pharmaceutical IndustriesPharmaceuticals | SEC FORM 4 Code M | —14,492 | filing |
| 28 May 2026filed 1 Jun 2026 | TEVA Teva Pharmaceutical Industriesoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —7,242 at $0.00 | filing |
| 28 May 2026filed 1 Jun 2026 | TEVA Teva Pharmaceutical Industriesoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —7,242 at $0.00 | filing |
| 2 Dec 2025filed 4 Dec 2025 | TEVA Teva Pharmaceutical Industriesoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —4,804 at $0.00 | filing |
| 2 Dec 2025filed 4 Dec 2025 | TEVA Teva Pharmaceutical IndustriesPharmaceuticals | SEC FORM 4 Code M | —4,804 | filing |
| 5 Jun 2025filed 9 Jun 2025 | TEVA Teva Pharmaceutical Industriesoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —14,492 at $0.00 | filing |
| 2 Dec 2024filed 4 Dec 2024 | TEVA Teva Pharmaceutical Industriesoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —4,804 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.